Malignant melanoma is one of the most dangerous forms of cancer. Around half of melanomas and about 7% of all other cancers carry a mutation in a protein called BRAF. This mutation disrupts the ...

A protein best known for its role in cancer may also be involved in how chronic nerve pain develops and persists. Researchers say drugs that already target this protein could open the door to a new ...

Chronic nerve pain can persist long after an injury and often responds poorly to standard pain medications. Researchers at The University of Texas MD Anderson Cancer Center now report evidence that ...

Genomic profiling is crucial in metastatic colorectal cancer (CRC) management: RAS and BRAF alterations govern prognosis and eligibility for targeted therapies. The expanding landscape of RAS directed ...

This article is based on a poster originally authored by Qiuyuan Yang, Kaiqiang Hu, Lei Liu, Tingting Guo, Haiyan Gu, Pengwei Pan, and Fang He. The study aimed to unravel the underlying processes that ...

Researchers have uncovered a stealth survival strategy that melanoma cells use to evade targeted therapy, offering a promising new approach to improving treatment outcomes. Melanoma, the deadliest ...

Researchers have uncovered a stealth survival strategy that melanoma cells use to evade targeted therapy, offering a promising new approach to improving treatment outcomes. Researchers have uncovered ...